News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
795,008 Results
Type
Article (49117)
Company Profile (714)
Press Release (745160)
Multimedia
Podcasts (147)
Webinars (27)
Section
Business (222840)
Career Advice (2730)
Deals (38770)
Drug Delivery (157)
Drug Development (87051)
Employer Resources (187)
FDA (17773)
Job Trends (16568)
News (377059)
Policy (36054)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2736)
Academic (1)
Accelerated approval (53)
Adcomms (34)
Allergies (186)
Alliances (54017)
ALS (227)
Alzheimer's disease (1916)
Antibody-drug conjugate (ADC) (515)
Approvals (18131)
Artificial intelligence (739)
Autoimmune disease (334)
Automation (59)
Bankruptcy (402)
Best Places to Work (12293)
BIOSECURE Act (23)
Biosimilars (235)
Biotechnology (436)
Bladder cancer (207)
Brain cancer (81)
Breast cancer (803)
Cancer (6264)
Cardiovascular disease (529)
Career advice (2316)
Career pathing (49)
CAR-T (358)
CDC (67)
Celiac Disease (3)
Cell therapy (987)
Cervical cancer (50)
Clinical research (75354)
Collaboration (2264)
Company closure (7)
Compensation (1460)
Complete response letters (101)
COVID-19 (2953)
CRISPR (119)
C-suite (1241)
Cystic fibrosis (161)
Data (8342)
Decentralized trials (3)
Denatured (35)
Depression (185)
Dermatology (94)
Diabetes (628)
Diagnostics (7439)
Digital health (59)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (356)
Drug pricing (235)
Drug shortages (36)
Duchenne muscular dystrophy (305)
Earnings (98747)
Editorial (74)
Employer branding (24)
Employer resources (163)
Events (132169)
Executive appointments (1169)
FDA (21698)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1849)
Gene editing (259)
Generative AI (62)
Gene therapy (802)
GLP-1 (1221)
Government (5070)
Grass and pollen (8)
Guidances (415)
Healthcare (20292)
HIV (86)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (105)
Immunology and inflammation (340)
Immuno-oncology (108)
Indications (198)
Infectious disease (3326)
Inflammatory bowel disease (234)
Inflation Reduction Act (15)
Influenza (142)
Intellectual property (308)
Interviews (503)
IPO (17822)
IRA (57)
Job creations (4639)
Job search strategy (1897)
JPM (68)
Kidney cancer (21)
Labor market (108)
Layoffs (668)
Leadership (48)
Legal (9063)
Liver cancer (108)
Longevity (35)
Lung cancer (822)
Lymphoma (448)
Machine learning (63)
Management (64)
Manufacturing (1142)
MASH (217)
Medical device (15003)
Medtech (15141)
Mergers & acquisitions (22223)
Metabolic disorders (1684)
mRNA (246)
Multiple sclerosis (199)
NASH (22)
Neurodegenerative disease (476)
Neuropsychiatric disorders (120)
Neuroscience (3577)
Neurotech (1)
NextGen: Class of 2026 (7220)
Non-profit (4689)
Now hiring (80)
Obesity (806)
Opinion (354)
Ovarian cancer (236)
Pain (274)
Pancreatic cancer (327)
Parkinson's disease (397)
Partnered (36)
Patents (626)
Patient recruitment (727)
Peanut (66)
People (65078)
Pharmaceutical (125)
Pharmacy benefit managers (37)
Phase 1 (23519)
Phase 2 (33151)
Phase 3 (24737)
Pipeline (9306)
Policy (369)
Postmarket research (2729)
Preclinical (10001)
Press Release (71)
Prostate cancer (328)
Psychedelics (68)
Radiopharmaceuticals (362)
Rare diseases (1197)
Real estate (6795)
Recruiting (76)
Regulatory (27727)
Reports (60)
Research institute (2545)
Resumes & cover letters (441)
Rett syndrome (40)
RNA editing (24)
RSV (97)
Schizophrenia (193)
Series A (314)
Series B (228)
Service/supplier (26)
Sickle cell disease (121)
Special edition (31)
Spinal muscular atrophy (179)
Sponsored (50)
Startups (4189)
State (2)
Stomach cancer (20)
Supply chain (137)
Tariffs (104)
The Weekly (109)
Vaccines (1238)
Venture capital (123)
Weight loss (545)
Women's health (131)
Worklife (24)
Date
Today (108)
Last 7 days (635)
Last 30 days (3548)
Last 365 days (31920)
2026 (14434)
2025 (31968)
2024 (37487)
2023 (42270)
2022 (53606)
2021 (58245)
2020 (56750)
2019 (49624)
2018 (37640)
2017 (35250)
2016 (35176)
2015 (41188)
2014 (35144)
2013 (30030)
2012 (32011)
2011 (32454)
2010 (30410)
Location
Africa (889)
Alabama (102)
Alaska (7)
Arizona (373)
Arkansas (16)
Asia (46002)
Australia (7619)
California (14012)
Canada (3893)
China (1489)
Colorado (597)
Connecticut (612)
Delaware (428)
Europe (102576)
Florida (2073)
Georgia (448)
Hawaii (4)
Idaho (67)
Illinois (1136)
India (100)
Indiana (646)
Iowa (25)
Japan (572)
Kansas (139)
Kentucky (54)
Louisiana (49)
Maine (89)
Maryland (1675)
Massachusetts (10222)
Michigan (400)
Minnesota (776)
Mississippi (6)
Missouri (159)
Montana (36)
Nebraska (30)
Nevada (152)
New Hampshire (91)
New Jersey (3715)
New Mexico (33)
New York (3671)
North Carolina (1886)
North Dakota (11)
Northern California (6989)
Ohio (431)
Oklahoma (25)
Oregon (53)
Pennsylvania (2779)
Puerto Rico (30)
Rhode Island (53)
South America (1320)
South Carolina (88)
South Dakota (2)
Southern California (5492)
Tennessee (217)
Texas (2252)
United States (49893)
Utah (420)
Vermont (1)
Virginia (349)
Washington D.C. (89)
Washington State (1147)
West Virginia (4)
Wisconsin (152)
Wyoming (2)
795,008 Results for "lannett company inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lannett Company, Lanexa Biologics and Sunshine Lake Pharma announce FDA Approval of LANGLARA™ an Interchangeable Biosimilar of Lantus® (insulin glargine)
May 4, 2026
·
5 min read
Press Releases
Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
May 12, 2026
·
3 min read
Business
Lannett Company, Inc. Enters Into Restructuring Support Agreement
Lannett Company, Inc. (OTCMKTS: LCIN) (the “Company” or “Lannett”) today announced that, together with certain of its subsidiaries (collectively with the Company, as applicable, the “Company Parties”), it has entered into a Restructuring Support Agreement (the “RSA”) with holders of more than 80% of its 7.750% senior secured notes due 2026.
May 1, 2023
·
7 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
March 11, 2026
·
3 min read
Deals
NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS
Lannett Company, Inc. (LCI) (“Lannett” or “the Company”) today announced that it received a written notice from the New York Stock Exchange (“NYSE”) dated April 19, 2023, notifying the Company that the NYSE will commence proceedings to delist the Company’s common stock from the NYSE.
April 20, 2023
·
3 min read
Deals
Lannett Company, Inc. Files Prepackaged Chapter 11 Cases to Significantly Strengthen Financial Position
Lannett Company, Inc. announced that it and certain of its subsidiaries have commenced prepackaged Chapter 11 cases in the United States Bankruptcy Court for the District of Delaware to effectuate the transactions contemplated by the Restructuring Support Agreement announced on May 1, 2023.
May 2, 2023
·
6 min read
Press Releases
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026
May 24, 2026
·
8 min read
Press Releases
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
April 2, 2026
·
4 min read
Press Releases
Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies
April 7, 2026
·
6 min read
1 of 79,501
Next
